Integration of genomic databases and bioinformatic approach to identify genomic variants for sjogren’s syndrome on multiple continents
DOI:
https://doi.org/10.12928/mf.v19i2.23706Keywords:
Sjogren’s syndrome, Autoimmune, Genome, Gene variationAbstract
An autoimmune disorder is an abnormality that causes a disease. It is caused by a weakened immune system. One of the autoimmune diseases is Sjogren’s syndrome, which affects the salivary and lacrimal glands and causes dry mouth, dry eyes, and dry skin. Sjogren’s syndrome influences humans of every age, with the symptoms occurring at the age of 45–55 years and rarely in children. One of the factors causing Sjogren’s syndrome is genetic disorders. To identify genes that can influence Sjogren’s syndrome in this study, we used several databases, including GWAS Catalog, HaploReg Version 4.1, GTEX portal, and Ensembl, particularly to identify the gene expression profiles of TNIP1, TNFAIP3, and IRF5 and the quantitative properties of locus’ expression. This research showed that the missense variants and splice donor rs2233290, rs2230926, and rs2004640 influenced the susceptibility of autoimmune diseases, especially Sjogren’s syndrome, in the fibroblast tissue, sigmoid tissue, sigmoid colon, skin, esophagus, and adrenal glands. The allele frequency of each variant was then assessed in African, American, European, and Asian populations. Our data showed that TNIP1, TNFAIP3, and IRF5 genes in African and American populations had higher frequencies than in the Asian population. This implies that the last of the aforementioned populations might be relatively susceptible to the autoimmune disease Sjogren’s syndrome.
References
Alani, H., Henty, J. R., Thompson, N. L., Jury, E., & Ciurtin, C. (2018). Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scandinavian Journal of Rheumatology, 47(2), 141–154. https://doi.org/10.1080/03009742.2017.1324909
Burbelo, P. D., Ambatipudi, K., & Alevizos, I. (2014). Genome-wide association studies in Sjögren’s syndrome: What do the genes tell us about disease pathogenesis? Autoimmunity Reviews, 13(7), 756–761. https://doi.org/10.1016/j.autrev.2014.02.002
Bush, W. S., & Moore, J. H. (2012). Chapter 11: Genome-Wide Association Studies. PLoS Computational Biology, 8(12). https://doi.org/10.1371/journal.pcbi.1002822
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014). A20 in inflammation and autoimmunity. Trends in Immunology, 35(1), 22–31. https://doi.org/10.1016/j.it.2013.10.005
Ciccacci, C., Latini, A., Perricone, C., Conigliaro, P., Colafrancesco, S., Ceccarelli, F., Priori, R., Conti, F., Perricone, R., Novelli, G., & Borgiani, P. (2019). TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients. Journal of Immunology Research, 2019. https://doi.org/10.1155/2019/6728694
Dieudé, P., Guedj, M., Wipff, J., Avouac, J., Fajardy, I., Diot, E., Granel, B., Sibilia, J., Cabane, J., Mouthon, L., Cracowski, J. L., Carpentier, P. H., Hachulla, E., Meyer, O., Kahan, A., Boileau, C., & Allanore, Y. (2009). Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis. Arthritis and Rheumatism, 60(1), 225–233. https://doi.org/10.1002/art.24183
Furqan, M., Kurniawan, R., & HP, K. (2020). Evaluasi Performa Support Vector Machine Classifier Terhadap Penyakit Mental. Jsinbis, 10(2), 203–210. https://doi.org/10.21456/vol10iss2pp203-210
GarcÃa-Carrasco, M., Fuentes-Alexandro, S., Escárcega, R. O., Salgado, G., Riebeling, C., & Cervera, R. (2006). Pathophysiology of Sjögren’s Syndrome. Archives of Medical Research, 37(8), 921–932. https://doi.org/10.1016/j.arcmed.2006.08.002
Gregersen, P. K., Kosoy, R., Lee, A. T., Lamb, J., Sussman, J., Simpfendorfer, K. R., Pirskanen-matell, R., Piehl, F., Pan-, Q., Verschuuren, J. J. G. M., Titulaer, M. J., & Niks, E. H. (2012). Risk for Myasthenia Gravis maps to 151Pro→ Ala change in TNIP1 and to HLA-B*08. Annals of Neurology, 72(6), 927–935. https://doi.org/10.1002/ana.23691.Risk
Hao, G., Li, Y., Liu, J., & Wo, M. (2014). arthritis of southern Chinese Han population : a case-control study. 7(12), 8958–8961.
Irham, L. M., Chou, W. H., Calkins, M. J., Adikusuma, W., Hsieh, S. L., & Chang, W. C. (2020). Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochemical and Biophysical Research Communications, 529(2), 263–269. https://doi.org/10.1016/j.bbrc.2020.05.179
Irham, L. M., Wong, H. S.-C., Chou, W.-H., Adikusuma, W., Mugiyanto, E., Huang, W.-C., & Chang, W.-C. (2020). Integration of genetic variants and gene network for drug repurposing in colorectal cancer. Pharmacological Research, 161, 105203. https://doi.org/10.1016/j.phrs.2020.105203
Kittridge, A., Routhouska, S. B., & Korman, N. J. (2011). Dermatologic manifestations of Sjögren syndrome. Journal of Cutaneous Medicine and Surgery, 15(1), 8–14. https://doi.org/10.2310/7750.2010.09033
Murti, B. T., Putri, A. D., Irham, L. M., Perwitasari, D. A., Hsieh, C.-M., Yang, P.-K., Kanchi, S., & Sabela, M. (2020). Current trends, achievements, and prospects of smart nanodevices in the global pharma market. In Nanomaterials in Diagnostic Tools and Devices (pp. 351–393). Elsevier. https://doi.org/10.1016/B978-0-12-817923-9.00013-4
Nezos, A., Gkioka, E., Koutsilieris, M., Voulgarelis, M., Tzioufas, A. G., & Mavragani, C. P. (2018). TNFAIP3 F127C coding variation in Greek primary sjogren’s syndrome patients. Journal of Immunology Research, 2018. https://doi.org/10.1155/2018/6923213
Nordmark, G., Kristjansdottir, G., Theander, E., Eriksson, P., Brun, J. G., Wang, C., Padyukov, L., Truedsson, L., Alm, G., Eloranta, M. L., Jonsson, R., Rönnblom, L., & Syvänen, A. C. (2009). Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren’s syndrome. Genes and Immunity, 10(1), 68–76. https://doi.org/10.1038/gene.2008.94
Qin, B., Wang, J., Yang, Z., Yang, M., Ma, N., Huang, F., & Zhong, R. (2015). Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Annals of the Rheumatic Diseases, 74(11), 1983–1989. https://doi.org/10.1136/annrheumdis-2014-205375
Rhodus, N. L. (2017). Sjögren’s syndrome. Quintessence International, 78(8), 689–699.
Shamilov, R., & Aneskievich, B. J. (2018). TNIP1 in autoimmune diseases: Regulation of toll-like receptor signaling. Journal of Immunology Research, 2018. https://doi.org/10.1155/2018/3491269
Stefanski, A. L., Tomiak, C., Pleyer, U., Dietrich, T., Burmester, G. R., & Dörner, T. (2017). The diagnosis and treatment of Sjögren’s syndrome. Deutsches Arzteblatt International, 114(20). https://doi.org/10.3238/arztebl.2017.0354
Sulistyani, N., & Nurkhasanah. (2017). The cytotoxic effect of Elephantopus scaber Linn extract against breast cancer (T47D) cells. IOP Conference Series: Materials Science and Engineering, 259, 012006. https://doi.org/10.1088/1757-899X/259/1/012006
Teos, L. Y., & Alevizos, I. (2017). Genetics of Sjögren’s syndrome. Clinical Immunology, 182, 41–47. https://doi.org/10.1016/j.clim.2017.04.018
Yao, C., Joehanes, R., Johnson, A. D., Huan, T., Liu, C., Freedman, J. E., Munson, P. J., Hill, D. E., Vidal, M., & Levy, D. (2017). Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits. American Journal of Human Genetics, 100(4), 571–580. https://doi.org/10.1016/j.ajhg.2017.02.003
Downloads
Published
Issue
Section
License
Authors who publish with Media Farmasi agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution 4.0 International License